|
JP7150712B2
(ja)
|
2016-11-18 |
2022-10-11 |
アーカス バイオサイエンシズ インコーポレイティド |
Ｃｄ７３媒介免疫抑制の阻害剤
|
|
CN110382544B
(zh)
|
2017-03-16 |
2023-12-22 |
先天制药公司 |
用于治疗癌症的组合物和方法
|
|
WO2018208980A1
(en)
|
2017-05-10 |
2018-11-15 |
Oric Pharmaceuticals, Inc. |
Cd73 inhibitors
|
|
WO2019068907A1
(en)
|
2017-10-06 |
2019-04-11 |
Innate Pharma |
RESTORATION OF T CELL ACTIVITY BY AXIS CD39 / CD73
|
|
WO2019090111A1
(en)
|
2017-11-03 |
2019-05-09 |
Oric Pharmaceuticals, Inc. |
Cd73 inhibitors
|
|
AU2019231781B2
(en)
|
2018-03-09 |
2025-02-13 |
Arcus Biosciences, Inc. |
Parenterally administered immune enhancing drugs
|
|
CN112423764A
(zh)
|
2018-04-30 |
2021-02-26 |
欧瑞克制药公司 |
Cd73抑制剂
|
|
WO2019232319A1
(en)
|
2018-05-31 |
2019-12-05 |
Peloton Therapeutics, Inc. |
Compositions and methods for inhibiting cd73
|
|
AU2019289646B2
(en)
|
2018-06-18 |
2025-10-23 |
Innate Pharma |
Compositions and methods for treating cancer
|
|
EP3843742A4
(en)
*
|
2018-08-28 |
2022-04-20 |
Jiangsu Hengrui Medicine Co., Ltd. |
CD73 INHIBITORS AND THEIR THERAPEUTIC USES
|
|
US11530234B2
(en)
|
2018-09-11 |
2022-12-20 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
CD73 inhibitors and pharmaceutical uses thereof
|
|
EP3849992A4
(en)
|
2018-09-11 |
2022-06-29 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
Cd73 inhibitors and pharmaceutical uses thereof
|
|
CN110885352B
(zh)
*
|
2018-09-11 |
2023-02-24 |
润佳（苏州）医药科技有限公司 |
Cd73抑制剂及其药学应用
|
|
CN113727999A
(zh)
|
2019-01-11 |
2021-11-30 |
奥默罗斯公司 |
用于治疗癌症的方法和组合物
|
|
CN112955444B
(zh)
*
|
2019-01-22 |
2023-12-12 |
江苏恒瑞医药股份有限公司 |
一种新型的小分子cd73抑制剂、其制备方法及其在医药上的应用
|
|
WO2020185859A1
(en)
|
2019-03-12 |
2020-09-17 |
Arcus Biosciences, Inc. |
Treatment of oncogene-driven cancers
|
|
EP3947463A4
(en)
|
2019-03-29 |
2022-12-21 |
Arcus Biosciences, Inc. |
TREATMENT OF CANCER USING AN IDENTIFIED ADENOSINE FINGERPRINT
|
|
EP3999517A4
(en)
|
2019-07-16 |
2023-07-12 |
Oric Pharmaceuticals, Inc. |
CD73 INHIBITORS
|
|
IL292570B2
(en)
|
2019-10-30 |
2024-04-01 |
Oric Pharmaceuticals Inc |
Cd73 inhibitors
|
|
IL295569B1
(en)
|
2020-03-19 |
2026-04-01 |
Arcus Biosciences Inc |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2ALPHA
|
|
US11820824B2
(en)
|
2020-06-02 |
2023-11-21 |
Arcus Biosciences, Inc. |
Antibodies to TIGIT
|
|
AU2021389685A1
(en)
*
|
2020-11-25 |
2023-07-06 |
Risen (Suzhou) Pharma Tech Co., Ltd. |
Cd73 inhibitors and pharmaceutical uses thereof
|
|
WO2022246177A1
(en)
|
2021-05-21 |
2022-11-24 |
Arcus Biosciences, Inc. |
Axl compounds
|
|
US20240226115A1
(en)
|
2021-05-21 |
2024-07-11 |
Arcus Biosciences, Inc. |
Axl inhibitor compounds
|
|
WO2023077046A1
(en)
|
2021-10-29 |
2023-05-04 |
Arcus Biosciences, Inc. |
Inhibitors of hif-2alpha and methods of use thereof
|
|
KR20250004779A
(ko)
|
2022-04-13 |
2025-01-08 |
길리애드 사이언시즈, 인코포레이티드 |
Trop-2 발현 암을 치료하기 위한 병용 요법
|
|
WO2023215719A1
(en)
|
2022-05-02 |
2023-11-09 |
Arcus Biosciences, Inc. |
Anti-tigit antibodies and uses of the same
|
|
CN119365476A
(zh)
*
|
2022-06-17 |
2025-01-24 |
上海森辉医药有限公司 |
一种环戊基腺苷衍生物及其药物用途
|
|
EP4554680A1
(en)
|
2022-07-15 |
2025-05-21 |
Arcus Biosciences, Inc. |
Inhibitors of hpk1 and methods of use thereof
|
|
WO2024020034A1
(en)
|
2022-07-20 |
2024-01-25 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
US20260115190A1
(en)
|
2022-09-14 |
2026-04-30 |
Arcus Biosciences, Inc. |
Dispersions of etrumadenant
|
|
EP4602041A1
(en)
|
2022-10-14 |
2025-08-20 |
Arcus Biosciences, Inc. |
Hpk1 inhibitors and methods of use thereof
|
|
US20240425497A1
(en)
|
2023-05-05 |
2024-12-26 |
Arcus Biosciences, Inc. |
Cbl-b Inhibitors and Methods of Use Thereof
|
|
CN116298323B
(zh)
*
|
2023-05-16 |
2023-08-22 |
南京联笃生物科技有限公司 |
一种用于诊断狼疮性肾炎的生物标志物及应用
|
|
WO2024243502A1
(en)
|
2023-05-25 |
2024-11-28 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
WO2025054339A1
(en)
|
2023-09-08 |
2025-03-13 |
Arcus Biosciences, Inc. |
Triazolopyridine compounds as inhibitors of kit
|
|
WO2025072330A1
(en)
|
2023-09-26 |
2025-04-03 |
Arcus Biosciences, Inc. |
Kit inhibitor compounds and methods of use thereof
|
|
US20260116868A1
(en)
|
2023-10-06 |
2026-04-30 |
Arcus Biosciences, Inc. |
Cbl-b inhibitors and methods of use thereof
|
|
TW202523302A
(zh)
|
2023-11-02 |
2025-06-16 |
美商阿克思生物科學有限公司 |
噻唑化合物及其使用方法
|
|
WO2025119278A1
(zh)
*
|
2023-12-07 |
2025-06-12 |
无锡和誉生物医药科技有限公司 |
一种cd73抑制剂药物组合物，其制备方法和应用
|
|
WO2025137640A1
(en)
|
2023-12-22 |
2025-06-26 |
Gilead Sciences, Inc. |
Azaspiro wrn inhibitors
|
|
WO2025193759A1
(en)
|
2024-03-12 |
2025-09-18 |
Gilead Sciences, Inc. |
Solid forms of an azolopyrimidine compound
|
|
WO2025233264A1
(en)
|
2024-05-07 |
2025-11-13 |
Innate Pharma |
Use of cd73 blocking agents in combination with anti-cd20 x cd3 t cell engagers
|
|
WO2026006759A1
(en)
|
2024-06-28 |
2026-01-02 |
Arcus Biosciences, Inc. |
Pharmaceutical compositions, dosage forms, and methods of making and using same
|